CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Instituto Hermes Pardini SA Company Snapshot
Instituto Hermes Pardini SA operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Instituto Hermes Pardini SA with three other pharmaceutical manufacturers in Latin America: Genomma Lab Internacional Sab De Cv of Mexico (2016 sales of 11.32 billion Mexican Pesos [US$604.63 million] of which 59% was International), Fleury SA (2.10 billion Brazilian Reals [US$650.15 million] of which 83% was Diagnostic Medicine), and Ouro Fino Saude Animal Participacoes SA (456.59 million Brazilian Reals [US$141.62 million] of which 79% was Production Animals).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Instituto Hermes Pardini SA
  Stock Performance Chart for Instituto Hermes Pardini SA
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 31.86
(Figures in Brazilian Reals)
1 Week 0.0%   13 Weeks -1.1%  
4 Weeks 3.7%   52 Weeks n/a  
 
Instituto Hermes Pardini SA Key Data:
  Ticker: PARD3 Country: Brazil
  Exchanges: OTH Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2016 Sales 899,414,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Brazilian Reals Market Cap: 4,172,978,037
  Fiscal Yr Ends: December Shares Outstanding: 130,978,595
  Share Type: Ordinary Closely Held Shares: 84,785,499
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.